These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19470727)

  • 1. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
    Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
    Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma.
    Bravo SB; García-Rendueles ME; Seoane R; Dosil V; Cameselle-Teijeiro J; López-Lázaro L; Zalvide J; Barreiro F; Pombo CM; Alvarez CV
    Clin Cancer Res; 2005 Nov; 11(21):7664-73. PubMed ID: 16278386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).
    Williamson EA; Wolf I; O'Kelly J; Bose S; Tanosaki S; Koeffler HP
    Oncogene; 2006 Mar; 25(9):1391-9. PubMed ID: 16331276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxA1 as a lineage-specific oncogene in luminal type breast cancer.
    Yamaguchi N; Ito E; Azuma S; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Tatsuta K; Inoue J; Semba K; Watanabe S
    Biochem Biophys Res Commun; 2008 Jan; 365(4):711-7. PubMed ID: 18039470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
    Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
    Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
    Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
    Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of the HSP72 by Foxa1 in MCF-7 human breast cancer cell line.
    Song L; Xu Z; Zhang C; Qiao X; Huang C
    Biochem Biophys Res Commun; 2009 Aug; 386(1):30-4. PubMed ID: 19486887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and functional interactions between homeodomain NKX2.1 and winged helix/forkhead FOXA1 in lung epithelial cells.
    Minoo P; Hu L; Xing Y; Zhu NL; Chen H; Li M; Borok Z; Li C
    Mol Cell Biol; 2007 Mar; 27(6):2155-65. PubMed ID: 17220277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of {beta}4 integrin knockdown by RNA interference in anaplastic thyroid carcinoma.
    Noh TW; Soung YH; Kim HI; Gil HJ; Kim JM; Lee EJ; Chung J
    Anticancer Res; 2010 Nov; 30(11):4485-92. PubMed ID: 21115897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer.
    De Falco V; Guarino V; Avilla E; Castellone MD; Salerno P; Salvatore G; Faviana P; Basolo F; Santoro M; Melillo RM
    Cancer Res; 2007 Dec; 67(24):11821-9. PubMed ID: 18089812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.
    Chiappetta G; De Marco C; Quintiero A; Califano D; Gherardi S; Malanga D; Scrima M; Montero-Conde C; Cito L; Monaco M; Motti ML; Pasquinelli R; Agosti V; Robledo M; Fusco A; Viglietto G
    Endocr Relat Cancer; 2007 Jun; 14(2):405-20. PubMed ID: 17639054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification.
    Elliott DD; Sherman SI; Busaidy NL; Williams MD; Santarpia L; Clayman GL; El-Naggar AK
    Hum Pathol; 2008 Jan; 39(1):15-20. PubMed ID: 17949783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma.
    Salvatore G; Nappi TC; Salerno P; Jiang Y; Garbi C; Ugolini C; Miccoli P; Basolo F; Castellone MD; Cirafici AM; Melillo RM; Fusco A; Bittner ML; Santoro M
    Cancer Res; 2007 Nov; 67(21):10148-58. PubMed ID: 17981789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of oncofetal fibronectin mRNA in thyroid anaplastic carcinoma.
    Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
    Jpn J Clin Oncol; 2007 Sep; 37(9):647-51. PubMed ID: 17704536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle.
    Visone R; Russo L; Pallante P; De Martino I; Ferraro A; Leone V; Borbone E; Petrocca F; Alder H; Croce CM; Fusco A
    Endocr Relat Cancer; 2007 Sep; 14(3):791-8. PubMed ID: 17914108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice.
    Kim S; Park YW; Schiff BA; Doan DD; Yazici Y; Jasser SA; Younes M; Mandal M; Bekele BN; Myers JN
    Clin Cancer Res; 2005 Mar; 11(5):1713-21. PubMed ID: 15755992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.
    Kim KS; Min JK; Liang ZL; Lee K; Lee JU; Bae KH; Lee MH; Lee SE; Ryu MJ; Kim SJ; Kim YK; Choi MJ; Jo YS; Kim JM; Shong M
    Clin Cancer Res; 2012 Jun; 18(11):3071-8. PubMed ID: 22472175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F-1 transcription factor is overexpressed in oxyphilic thyroid tumors.
    Volante M; Croce S; Pecchioni C; Papotti M
    Mod Pathol; 2002 Oct; 15(10):1038-43. PubMed ID: 12379749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.